JOURNAL SCANS
Our oncology experts identify the most important cancer-related articles from leading medical journals.
Editors' Choice
Neoadjuvant Trastuzumab improves event-free survival in HER2+ locally advanced or inflammatory breast cancer.
Our oncology experts identify the most important cancer-related articles from leading medical journals.